|
US5952294A
(en)
|
1996-07-31 |
1999-09-14 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptidyl prodrugs and methods of making and using the same
|
|
DE10005302A1
(de)
*
|
2000-02-07 |
2002-01-17 |
Gruenenthal Gmbh |
Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate
|
|
EP1399467A4
(en)
|
2001-05-09 |
2004-09-15 |
Newbiotics Inc |
PRODRUGS ACTIVATED BY PEPTIDDEFORMYLASE
|
|
DE10137488A1
(de)
*
|
2001-08-03 |
2003-02-20 |
Gruenenthal Gmbh |
Salze substituierter 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate
|
|
DE10236910A1
(de)
*
|
2002-08-12 |
2004-03-11 |
Grünenthal GmbH |
Substituierte 1,2,3,4-Tetrahydrochinolinderivate
|
|
WO2004108681A1
(en)
*
|
2003-06-06 |
2004-12-16 |
Fibrogen, Inc. |
Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
|
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ｏｘ４０ｌ抗體
|
|
AU2005316739A1
(en)
*
|
2004-12-13 |
2006-06-22 |
Galileo Pharmaceuticals, Inc. |
Spiro derivatives as lipoxygenase inhibitors
|
|
PT2343320T
(pt)
|
2005-03-25 |
2018-01-23 |
Gitr Inc |
Anticorpos anti-gitr e as suas utilizações
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
US8314234B2
(en)
|
2006-09-25 |
2012-11-20 |
Janssen Pharmaceutica N.V. |
Bicyclic pyrimidine kinase inhibitors
|
|
GB0704407D0
(en)
|
2007-03-07 |
2007-04-18 |
Glaxo Group Ltd |
Compounds
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
US8591886B2
(en)
|
2007-07-12 |
2013-11-26 |
Gitr, Inc. |
Combination therapies employing GITR binding molecules
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
EP2249853A4
(en)
|
2008-01-30 |
2012-12-26 |
Univ Indiana Res & Tech Corp |
ESTER BASED PEPTIDE PRODRUGS
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
KR101790802B1
(ko)
|
2009-09-03 |
2017-10-27 |
머크 샤프 앤드 돔 코포레이션 |
항-ｇｉｔｒ 항체
|
|
ES2722300T3
(es)
|
2009-12-10 |
2019-08-09 |
Hoffmann La Roche |
Anticuerpos que se unen preferentemente al dominio extracelular 4 de CSF1R y su uso
|
|
WO2011107494A1
(de)
*
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2542256B1
(en)
|
2010-03-04 |
2019-05-22 |
MacroGenics, Inc. |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
|
US9169323B2
(en)
|
2010-03-05 |
2015-10-27 |
Hoffmann-La Roche Inc. |
Antibodies against human CSF-1R
|
|
JP5989547B2
(ja)
|
2010-03-05 |
2016-09-07 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ヒトｃｓｆ−１ｒに対する抗体及びその使用
|
|
HRP20190047T1
(hr)
|
2010-05-04 |
2019-02-22 |
Five Prime Therapeutics, Inc. |
Protutijela koja se vežu na csf1r
|
|
MX337040B
(es)
|
2010-09-09 |
2016-02-09 |
Pfizer |
Moleculas de union a 4-1bb.
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
KR101764096B1
(ko)
|
2011-11-28 |
2017-08-02 |
메르크 파텐트 게엠베하 |
항-ｐｄ-ｌ1 항체 및 그의 용도
|
|
RU2658603C2
(ru)
|
2011-12-15 |
2018-06-21 |
Ф.Хоффманн-Ля Рош Аг |
Антитела против человеческого csf-1r и их применения
|
|
JO3398B1
(ar)
*
|
2011-12-22 |
2019-10-20 |
Novartis Ag |
مشتقات 2،3- ثانى هيدرو- بنزو[1,4] أوكسازين والمركبات المتعلقة بها كمثبطات كيناز فسفواينوسيتيد-3 (pi3k) لمعالجة على سبيل المثال التهاب المفاصل الروماتيدي
|
|
KR20140127855A
(ko)
|
2012-02-06 |
2014-11-04 |
제넨테크, 인크. |
Csf1r 억제제를 사용하는 조성물 및 방법
|
|
WO2013122897A1
(en)
*
|
2012-02-13 |
2013-08-22 |
Amgen Inc. |
Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
RU2670743C9
(ru)
|
2012-05-11 |
2018-12-19 |
Файв Прайм Терапьютикс, Инк. |
Способы лечения состояний антителами, которые связывают рецептор колониестимулирующего фактора 1 (csf1r)
|
|
CN102786512A
(zh)
*
|
2012-05-31 |
2012-11-21 |
中国人民解放军军事医学科学院毒物药物研究所 |
N-芳基不饱和稠环叔胺类化合物及其制备方法和抗肿瘤应用
|
|
UY34887A
(es)
|
2012-07-02 |
2013-12-31 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
|
|
CN107759690A
(zh)
|
2012-08-31 |
2018-03-06 |
戊瑞治疗有限公司 |
用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法
|
|
CA2890897A1
(en)
|
2012-11-14 |
2014-05-22 |
The Board Of Regents Of The University Of Texas System |
Inhibition of hif-2.alpha. heterodimerization with hif 1.beta. (arnt)
|
|
AU2014307958B2
(en)
|
2013-08-13 |
2018-04-05 |
Philip Morris Products S.A. |
Smoking article comprising a blind combustible heat source
|
|
PL3417851T3
(pl)
*
|
2013-09-09 |
2020-12-14 |
Peloton Therapeutics, Inc. |
Etery arylowe i ich zastosowanie
|
|
US9399640B2
(en)
|
2013-11-26 |
2016-07-26 |
Incyte Corporation |
Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
|
|
US9884843B2
(en)
|
2013-12-16 |
2018-02-06 |
Peloton Therapeutics, Inc. |
Cyclic sulfone and sulfoximine analogs and uses thereof
|
|
WO2016057242A1
(en)
|
2014-10-10 |
2016-04-14 |
The Board Of Regents Of The University Of Texas System |
HIF-2α INHIBITORS FOR TREATING IRON OVERLOAD DISORDERS
|
|
WO2016145236A1
(en)
|
2015-03-11 |
2016-09-15 |
Peloton Therapeutics, Inc. |
Hif-2-alpha inhibitor polymorphs
|
|
US10512626B2
(en)
|
2015-03-11 |
2019-12-24 |
Peloton Therapeautics, Inc. |
Compositions for use in treating glioblastoma
|
|
WO2016144826A1
(en)
|
2015-03-11 |
2016-09-15 |
Peloton Therapeutics, Inc. |
Substituted pyridines and uses thereof
|
|
WO2016144825A1
(en)
|
2015-03-11 |
2016-09-15 |
Peloton Therapeutics, Inc. |
Aromatic compounds and uses thereof
|
|
US10278942B2
(en)
*
|
2015-03-11 |
2019-05-07 |
Peloton Therapeutics, Inc. |
Compositions for use in treating pulmonary arterial hypertension
|
|
WO2016168510A1
(en)
|
2015-04-17 |
2016-10-20 |
Peloton Therapeutics, Inc. |
Combination therapy of a hif-2-alpha inhibitor and an immunotherapeutic agent and uses thereof
|
|
US9796697B2
(en)
|
2015-06-12 |
2017-10-24 |
Peloton Therapeutics, Inc. |
Tricyclic inhibitors of HIF-2-alpha and uses thereof
|
|
US20190048421A1
(en)
|
2015-09-21 |
2019-02-14 |
The Board Of Regents Of The University Of Texas System |
Biomarkers of response to hif-2-alpha inhibition in cancer and methods for the use thereof
|
|
WO2017120508A1
(en)
|
2016-01-08 |
2017-07-13 |
Arcus Biosciences, Inc. |
Modulators of 5'-nucleotidase, ecto and the use thereof
|
|
WO2018031680A1
(en)
|
2016-08-10 |
2018-02-15 |
Fronthera U.S. Pharmaceuticals Llc |
Novel compounds, uses and methods for their preparation
|
|
EP3518934A4
(en)
|
2016-10-03 |
2020-06-24 |
Arcus Biosciences, Inc. |
Inhibitors of adenosine 5'-nucleotidase
|
|
WO2018094148A1
(en)
|
2016-11-18 |
2018-05-24 |
Arcus Biosciences, Inc. |
Inhibitors of cd73-mediated immunosuppression
|
|
HUE064141T2
(hu)
|
2017-01-20 |
2024-02-28 |
Arcus Biosciences Inc |
Azolopirimidin rákkal összefüggõ rendellenességek kezelésére
|
|
ES2953349T3
(es)
|
2017-05-05 |
2023-11-10 |
Arcus Biosciences Inc |
Derivados de quinazolina-piridina para el tratamiento de trastornos relacionados con el cáncer
|
|
PL3634417T3
(pl)
|
2017-05-17 |
2023-09-25 |
Arcus Biosciences, Inc. |
Pochodne chinazolino-pirazolowe do leczenia chorób związanych z nowotworem
|
|
FR3071726B1
(fr)
*
|
2017-09-29 |
2020-09-04 |
Univ Paris Sud |
Agents inhibant la proteine tctp pour le traitement de maladies proliferatives et de maladies infectieuses
|
|
TW201942115A
(zh)
|
2018-02-01 |
2019-11-01 |
美商輝瑞股份有限公司 |
作為抗癌藥之經取代的喹唑啉和吡啶並嘧啶衍生物
|
|
CN108191860B
(zh)
|
2018-02-12 |
2019-12-10 |
中国医科大学 |
一种HIF-2α小分子抑制剂及其用途
|
|
EP3774709A4
(en)
|
2018-03-28 |
2021-12-22 |
Peloton Therapeutics, Inc. |
METHOD FOR REDUCING INFLAMMATION OF THE DIGESTIVE SYSTEM USING INHIBITORS OF HIF-2-ALPHA
|
|
PL3829581T3
(pl)
|
2018-07-27 |
2024-07-01 |
Arcus Biosciences, Inc. |
Antagoniści pirydonu a2r
|
|
WO2020046813A1
(en)
|
2018-08-27 |
2020-03-05 |
Arcus Biosciences, Inc. |
Cd73 inhibitors
|
|
US12171741B2
(en)
|
2018-09-11 |
2024-12-24 |
Nikang Therapeutics, Inc. |
2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors
|
|
WO2020081695A1
(en)
|
2018-10-17 |
2020-04-23 |
Nikang Therapeutics, Inc. |
Indane derivatives as hypoxia inducible factor-2(alpha) inhibitors
|
|
CN112955130A
(zh)
|
2018-10-30 |
2021-06-11 |
佩洛通治疗公司 |
包含取代茚满的固体分散体和药物组合物及其制备和使用方法
|
|
TWI828800B
(zh)
|
2018-11-16 |
2024-01-11 |
美商阿克思生物科學有限公司 |
Arg1及/或arg2之抑制劑
|
|
CN109776607B
(zh)
|
2019-02-21 |
2021-06-04 |
青岛海洋生物医药研究院 |
芳基磷氧类和芳基磷硫类化合物及其制备方法和应用
|
|
IL287258B2
(en)
|
2019-04-18 |
2026-01-01 |
Nikang Therapeutics Inc |
Inhibitors as tetrahydro-1h-cyclopenta[cd] indene derivatives as hypoxia inducible factor -2alpha
|
|
US20220274914A1
(en)
|
2019-07-22 |
2022-09-01 |
Nikang Therapeutics, Inc. |
Tricyclic derivatives as hypoxia inducible factor-2(alpha) inhibitors
|
|
CA3162574A1
(en)
|
2019-11-26 |
2021-06-03 |
Merck Patent Gmbh |
Condensed thiophene derivatives as hypoxia inducible factor (hif) inhibitors
|
|
JP2023504623A
(ja)
|
2019-12-04 |
2023-02-06 |
アーカス バイオサイエンシーズ，インコーポレーテッド |
Ｈｉｆ－２アルファの阻害剤
|
|
CN111303053B
(zh)
|
2020-03-16 |
2023-01-17 |
中国海洋大学 |
环戊并[d]嘧啶类化合物及其药学上可接受的盐、溶剂合物或者前药以及应用
|
|
CN119118872A
(zh)
|
2020-03-19 |
2024-12-13 |
艾库斯生物科学有限公司 |
作为HIF-2α抑制剂的四氢化萘和四氢喹啉化合物
|